One day, the promise of precision oncology will be realized. We’re committed to helping labs bring that day closer. From our Ion Torrent next-generation sequencing (NGS) systems to our one-day Oncomine Precision Assay and curated, accessible bioinformatics, we’re doing everything we can to help labs advance a new paradigm for genomic profiling.
Explore our next-generation sequencers and see which one is right for your lab.
The Ion Torrent Genexus System automates sample and library preparation, sequencing, analysis, and reporting. The Genexus Purification System and Genexus Integrated Sequencer with Genexus Software work together seamlessly, tracking sample information and results automatically through the process. This automated system reduces manual steps and facilitates quality data and quick reports.
Managing, and ultimately interpreting, the significant quantities of variant data produced by NGS and cytogenetics workflows presents a formidable challenge. In cancer research specifically, the wide range of variants in tumor and blood samples presents challenges for efficient, accurate, and thorough analysis of cancer-relevant data.
Torrent Suite Software
Intuitive, web-based interface through the Torrent Browser makes it fast and easy to plan, monitor, and view high-quality data for analysis.
Produces clear and concise reports by linking relevant biomarkers with a curated knowledgebase of information from public sources
Ion Reporter Software
Simplify your bioinformatics path to discovery. By helping to remove barriers in NGS data analysis, this software enables you to focus on finding the biological meaning of your data.
Check out our educational resources for NGS in precision oncology.
The Oncomine Clinical Research Grant Program supports investigator-initiated studies (IIS) and education projects on molecular profiling in oncology with the goal to increase high quality molecular profiling and to help democratize the future of precision medicine.
Proposal reviews are conducted by independent and internationally recognized experts together with Thermo Fisher Scientific medical and scientific leadership. Funding is considered based on scientific merit.
For Research Use Only. Not for use in diagnostic procedures.